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Summary
We all experience a host of common life stressors such as the death of a family member, medical 
illness, and financial uncertainty. While most of us are resilient to such stressors, continuing to 
function normally, for a subset of individuals, experiencing these stressors increases the likelihood 
of developing treatment-resistant, chronic psychological problems, including depression and 
anxiety. It is thus paramount to identify predictive markers of risk, particularly those reflecting 
fundamental biological processes that can be targets for intervention and prevention. Using data 
from a longitudinal study of 340 healthy young adults, we demonstrate that individual differences 
in threat-related amygdala reactivity predict psychological vulnerability to life stress occurring as 
much as 1 to 4 years later. These results highlight a readily assayed biomarker, threat-related 
amygdala reactivity, which predicts psychological vulnerability to commonly experienced 
stressors and represents a discrete target for intervention and prevention.
Introduction
Exposure to stressful life events is a robust risk factor for the development of treatment-
resistant, chronic psychological problems including major depression and anxiety disorders 
(Faravelli, 1985; Galea et al., 2002; Kendler et al., 1999). However, whereas most 
individuals experience stressful life events at some point, the lifetime prevalence for major 
depression and anxiety disorders is 17% and 29%, respectively (Kessler et al., 2005), 
indicating that only a subset of individuals experiencing life events will ultimately develop 
psychopathology. The ability to prospectively identify which individuals are at greatest risk 
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represents a critical gap in our ability to effectively intervene and prevent the emergence of 
disabling psychological problems. Focusing such efforts on biological processes involved in 
stress reactivity and regulation is particularly important as they represent not only predictive 
markers of risk but also discrete targets for intervention and prevention.
Amygdala reactivity to threat is a prime candidate biomarker for psychological risk to 
common stressors given its critical roles in threat detection, stress reactivity, and memory 
for negative information (Herman and Cullinan, 1997; Kim et al., 2003; Murty et al., 2010; 
Pessoa and Ungerleider, 2004). Thus, relatively greater amygdala reactivity to common 
stressors could lead to an altered stress response and biased appraisal and memory of 
stressful events, all of which are core symptoms and features of depression and anxiety 
disorders (Burke et al., 2005; Espejo et al., 2012; Fales et al., 2008; Hamilton and Gotlib, 
2008). Not surprisingly, heightened threat-related amygdala reactivity is consistently 
observed in patients with depression and anxiety (Etkin and Wager, 2007; Groenewold et 
al., 2013). However, cross-sectional research in patients cannot determine whether 
heightened amygdala reactivity is a premorbid vulnerability present before the development 
of symptoms, or whether this neural phenotype is a secondary correlate that emerges as a 
downstream consequence of the onset of symptoms. Prospective research is required to 
address this limitation and test whether amygdala reactivity predicts internalizing symptoms 
at a future point in time, controlling for baseline symptom levels.
Adolescents at heightened risk for the development of depression and anxiety through a 
positive family history for these disorders evidence heightened amygdala reactivity to threat 
(Joormann et al., 2012; Monk et al., 2008; Swartz et al., in press), suggesting that this neural 
biomarker can be observed before the onset of disorder. It remains to be determined, 
however, whether such heightened amygdala reactivity predicts the development of 
internalizing symptoms following the experience of stress in the future. Indeed, only two 
studies with small samples have examined such a prospective association, with both finding 
that relatively increased amygdala reactivity measured before the experience of a major 
traumatic event (i.e., warzone combat (Admon et al., 2009) or a terrorist attack (McLaughlin 
et al., 2014)) predicted greater subsequent posttraumatic stress disorder symptoms. While 
these findings suggest that threat-related amygdala reactivity may represent a predictive 
biomarker of psychological vulnerability to extreme and rare forms of trauma, we do not 
know if threat-related amygdala reactivity has similar predictive utility in the broader 
population who experience milder forms of common stressful life events.
To examine whether relatively increased threat-related amygdala reactivity prospectively 
predicts psychological vulnerability to common life stressors, we used functional magnetic 
resonance imaging (fMRI) to assess baseline threat-related amygdala reactivity in 753 
participants aged 18-22 years old, all of whom were free of current depression or anxiety 
disorders. We chose a sample of young adults as this developmental stage marks the 
beginning of a peak period of risk for the emergence of a number of internalizing disorders, 
including major depression, panic disorder, generalized anxiety disorder, and posttraumatic 
stress disorder (Kessler et al., 2005). A widely utilized and well-established face matching 
paradigm was used to robustly elicit threat-related amygdala reactivity (Nikolova et al., 
2014; Prather et al., 2013). At the time of scanning, participants reported the number of 
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stressful life events they had experienced in the prior year, as well as their experience of 
childhood trauma and their current levels of depression and anxiety symptoms. We used 
these baseline measures as covariates in all analyses to test whether amygdala reactivity 
prospectively predicts future psychological problems as a function of stress above and 
beyond participants’ reported symptoms and stress levels at baseline.
After successful completion of the baseline protocol including fMRI, all participants were 
subsequently contacted by e-mail every 3 months and invited to complete a short online 
assessment of their current mood and experience of stressful life events since their last 
assessment. At baseline and each follow-up, participants were given a checklist (Clements 
and Turpin, 1996) of stressful life events commonly experienced by students (e.g., death of a 
very good friend, major car accident, parent losing a job) and were asked to indicate which 
events had occurred since the last assessment as well as the impact of that event. We 
calculated the sum of all impact scores for each event reported; thus, higher scores can 
reflect both a greater number of events as well as more severe events. Symptoms of 
depression and anxiety were reported at baseline and each follow-up assessment (Watson et 
al., 1995).
Results
Amygdala reactivity to threat
Functional MRI results were first examined in SPM8 to ensure that the task elicited 
predicted activation in the amygdala (Figure 1A). As expected, the contrast of fearful and 
angry faces > shapes was associated with bilateral amygdala reactivity: left amygdala, 
t(810)=28.7, p<.001 FWE-corrected, peak coordinates (x,y,z): (−22, −6, −18), and right 
amygdala, t(810)=32.5, p<.001 corrected, (28, −4, 20). A mean parameter estimate 
reflecting amygdala reactivity as a function of our task (i.e., fearful and angry facial 
expressions vs. shapes) was extracted for each participant and entered into regression 
models in MPlus v7.
Model A: Using amygdala reactivity to predict internalizing symptoms as a function of 
recent stress
To test our hypothesis that baseline threat-related amygdala reactivity predicts psychological 
vulnerability to the subsequent experience of common life stressors at any point in the 
future, we first created a model (Model A; Figure 1B) using the largest sample of 
participants that completed an online assessment at any time post-scanning. For participants 
that completed multiple assessments, we selected data from the most recent assessment 
available. Follow-up assessments were available from a total of 340 participants, and were 
collected approximately 1 year post-scanning (M=468 days, Min-Max=90-1402). Model A 
was significant (Table S1; p<.001), with the interaction between amygdala reactivity and life 
stress reported post-scanning predicting the severity of symptoms (B=2.01, SE=.7, 
t(339)=3.08, p=.002). Specifically, individuals with relatively heightened amygdala 
reactivity at baseline who also reported experiencing greater life stress subsequent to 
scanning had significantly greater symptoms at follow-up (Figure 1C and Figure S1). 
Exploratory whole-brain results are reported in Table S2.
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Model B: Long-term predictive utility of amygdala reactivity
While Model A confirmed our hypothesis that amygdala reactivity represents a predictive 
biomarker of psychological vulnerability to common life stressors, this model included 
participants who completed post-scanning assessments in relatively close proximity to the 
scan (e.g., 3 months). To determine the long-term predictive utility of threat-related 
amygdala reactivity, we next analyzed data from only those participants who completed an 
online assessment at least one year post-scanning (Model B; Figure 2A). For this model, 192 
participants were included who completed their assessment on average 2 years post-baseline 
(M=683 days, Min-Max=365-1402). Model B was significant (Table S3; p<.001), with the 
interaction between amygdala reactivity and life stress predicting symptom severity 
following stress occurring approximately 2 years later (B=1.75, SE=.8, t(191)=2.33, p=.02). 
Again, participants with relatively heightened amygdala reactivity at baseline who 
experienced relatively high life stress post-scanning reported the greatest symptoms (Figure 
2B and Figure S2).
Model C: Prospective assessment of stressful life events
A limitation of our previous models is that we used concurrent reports of life stress and 
internalizing symptoms from the most recent assessment available. Participants experiencing 
greater negative affect at the time of assessment may be biased toward indicating greater 
severity of recent life stress. Therefore, we created a final model (Model C, Figure 3A) in 
which life stress was assessed prospective to the reporting of symptoms. To equate 
participants in terms of when stressful life events and symptoms were measured, we 
obtained symptoms from assessments completed approximately 1 year post-scanning. We 
then computed the mean life stress score for all assessments completed prior to this, yielding 
a prospective set of variables including threat-related amygdala reactivity at baseline, life 
stress that occurred post-scanning, and symptoms approximately 1 year post-scanning. Data 
from 99 participants were available for this analysis. The moderation Model C was 
significant (Table S3; p<.001), indicating a significant interaction between threat-related 
amygdala reactivity and subsequent life stress in predicting internalizing symptoms 1 year 
later (B=5.56, SE=1.9, t(98)=2.96, p=.003). As in our previous models, individuals with 
relatively heightened amygdala reactivity who experienced greater life stress post-scanning 
reported greater internalizing symptoms 1 year later (Figure 3B and Figure S3). The 
interaction between amygdala reactivity and life stress explained an additional 5% of the 
variance in symptoms, above and beyond all covariates, including symptoms reported at 
baseline.
Discussion
Using data from a large longitudinal study of healthy young adults, we provide novel 
evidence for the utility of threat-related amygdala reactivity - assessed with fMRI - as a 
predictive biomarker of risk for broad psychological vulnerability to commonly experienced 
stressful life events. Our neural risk biomarker predicted vulnerability consistent with a 
diathesis-stress model in both the short- and long-term as well as independently of negative 
reporting biases. Critically, we did not find a main effect of amygdala reactivity in 
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predicting future internalizing symptoms, indicating that this neural biomarker predicts 
greater symptoms only within the context of experiencing relatively high life stress.
Remarkably, amygdala reactivity measured at one time point significantly predicted 
internalizing symptoms, above and beyond baseline symptoms, as much as 1 to 4 years into 
the future, indicating possible utility of this neural phenotype for prediction of long-term 
internalizing outcomes. However, it is important to note that the interaction between 
amygdala reactivity and stress only explained an additional 1-5% of the variance in 
symptoms, with the long-term model (Model B) evidencing the weakest effect. There are 
several methodological limitations of the current study that may have led us to 
underestimate the size of this effect. First, participants were not guaranteed payment for 
completing follow-up online assessments but entered into a larger gift card raffle. Thus, 
missing data may have biased our results. Second, life stress was assessed through a self-
report checklist rather than through a more objective approach such as a calendar interview. 
Third, our non-clinical sample of undergraduate students was generally low-risk and the 
associated range and variability in internalizing symptoms truncated in comparison to 
clinical or high-risk samples. We anticipate that future research addressing these limitations 
may find larger effect sizes than those reported in the present study. Nevertheless, these 
results underscore the need to identify additional biomarkers, whether neural or genetic, that 
can explain additional variance in addition to or in interaction with that accounted for by 
threat-related amygdala reactivity.
Notably, a range of previously identified risk factors for depression and anxiety disorders 
are all associated with relatively increased amygdala reactivity to threat (Bogdan et al., 
2012; Swartz et al., in press; Nikolova et al., 2014; White et al., 2012), and our biomarker is 
consistent with specific pathways of increased risk, including exaggerated hypothalamic-
pituitary-adrenal axis stress responsiveness and cognitive biases. Although our follow-up 
assessments did not allow for direct mapping of threat-related amygdala reactivity onto 
formal clinical diagnosis, the increased stress-related symptoms of depression and anxiety 
predicted by amygdala reactivity have been directly associated with dysfunction 
(Bredemeier et al., 2010; Buckby et al., 2007), and relatively increased amygdala reactivity 
is consistently observed in patients with clinical depression and anxiety disorders (Etkin and 
Wager, 2007; Groenewold et al., 2013). Thus, threat-related amygdala reactivity represents a 
predictive neural biomarker through which a range of risk factors may create a common 
diathesis for psychological vulnerability to the experience of common life stressors in the 
general population. As such, relatively increased threat-related amygdala reactivity further 
represents a discrete biological mechanism that can be targeted in the development of novel 
strategies for more effective prevention of otherwise chronic and treatment-resistant 
psychiatric disorders. The amygdala, of course, represents only one node of an extended 
corticolimbic circuit supporting emotion processing and stress responsiveness. Other circuit 
nodes include the hypothalamus, brainstem, insula, hippocampal formation, and prefrontal 
cortex. Future research using paradigms designed to target these other circuit nodes as well 
as their dynamic interactions may further illuminate biological pathways through which 
individual differences in stress responsiveness may eventually manifest as disorder.
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Young adult college students were recruited as part of the Duke Neurogenetics Study. All 
procedures were approved by the Duke University Medical Center and participants provided 
informed consent before participating in the study. Participants were included in the present 
sample if they met the following criteria: 1) free of medical diagnoses of cancer, stroke, 
diabetes, chronic kidney or liver disease, or lifetime history of psychotic symptoms; 2) no 
use of psychotropic, glucocorticoid, or hypolipidemic medication; 3) no conditions affecting 
cerebral blood flow and metabolism (e.g., hypertension); and 4) met quality control criteria 
for functional MRI scanning. Moreover, due to our interest in predicting internalizing 
symptoms post-scanning, we excluded any participants with a current mood, anxiety, or 
eating disorder diagnosis at the time of scanning, based on the electronic Mini International 
Neuropsychiatric Interview (Sheehan et al., 1998). A covariate was included in all analyses 
to control for participants with a non-internalizing diagnosis (e.g., substance abuse) or with a 
past internalizing diagnosis. A total of 811 participants met inclusion criteria for the imaging 
data (see Supplemental Experimental Procedures for quality control criteria), 57 were 
excluded for current psychopathology, and 1 participant was missing data, leaving 753 
participants (57% female) ranging in age from 18 to 22 available for analyses (Table 1).
Measures: Baseline Assessments
Functional MRI—Participants performed a face matching task that has been to shown to 
elicit robust amygdala reactivity across a range of studies and samples, including the present 
sample (Nikolova et al., 2014; Prather et al., 2013). The current paradigm consisted of four 
blocks of face matching interleaved with five blocks of a shape-matching sensorimotor 
control task. During face-matching blocks, participants viewed a trio of faces and selected 
one of two faces (on bottom) matching a target face (on top). Each face block contained one 
of the following expressions: fearful, angry, surprised, and neutral. Each trial in the face-
matching blocks lasted for 4 seconds with a variable interstimulus interval (ISI) of 2 to 6 
seconds (M=4 seconds), for a total block length of 48 seconds. In the control blocks, each of 
the six shape trios was presented for 4 seconds with a fixed ISI of 2 seconds, for a total 
block length of 36 seconds. Total task time was 390 seconds. Details regarding fMRI 
acquisition are reported in the Supplemental Experimental Procedures.
Covariates—Because we were interested in predicting the future development of 
internalizing symptoms, we controlled for internalizing symptoms at baseline using the 
Mood and Anxiety Symptoms Questionnaire (MASQ) Short Form (Watson et al., 1995). 
Scores across all subscales (general distress/depression, general distress/anxiety, anxious 
arousal, and anhedonia) were summed to create a measure of total internalizing symptoms. 
Likewise, because we were interested in the effect of life stress occurring post-scanning, we 
controlled for life stress reported at baseline. To assess life stress, participants were 
administered the Life Events Scale for Students (LESS; Clements and Turpin, 1996), to 
measure the number of life events that occurred in the past 12 months. Participants also 
rated the impact that the life event had on them on a 1 to 4 scale (4=severe impact). The 
impact score for each event reported was summed to yield a LESS total impact score; higher 
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values indicate both greater number and severity of life events. Additional covariates are 
described in the Supplement.
Measures: Post-scanning assessments
Participants were re-contacted post-scanning to complete follow-up assessments online 
every 3 months. Successful completers were entered into a raffle for one $50 Amazon gift 
card for each round of follow-up assessments. The same questions from the LESS were used 
to assess stressful life events in the post-scanning questionnaires; however, for these 
assessments participants were asked to report if any life events had occurred since their last 
assessment. Participants also completed the MASQ Short Form during these post-scanning 
assessments. In accordance with our first model (Model A), we selected the most recent 
assessment available for all participants, and obtained the life stress total impact score from 
the LESS and total internalizing symptoms from the MASQ at this most recent assessment. 
For Model B, we took a similar approach, except that we limited this model to those 
participants who had completed an assessment at least 1 year post-scanning. In accordance 
with our final model (Model C), we selected MASQ symptom scores from questionnaires 
completed approximately 1 year post-scanning (the inclusion range was set to 365-455 days 
post-scanning, to take into account the fact that participants may not have completed the 
assessment exactly 365 days post-scanning). We then computed the mean of the LESS 
impact score from each assessment completed before that (Figure 3A). Extra care was taken 
in quality control procedures for these assessments, given that they were administered 
online. Specifically, individual item responses were examined for any obvious patterns of 
false reporting (e.g., a participant indicates a yes for every stressful life event on the LESS). 
Attrition analyses are reported in the Supplemental Experimental Procedures.
Analyses
Functional MRI—Functional MRI data were processed in SPM8 using the standard pre-
processing stream used in previously published research from the Duke Neurogenetics 
Study. Further details on the procedure and quality control criteria are reported in the 
Supplemental Experimental Procedures. We hypothesized that results would be specific to 
threatening facial expressions (fearful and angry), thus the main contrast analyzed was 
fearful and angry faces > shapes. To examine the specificity of effects to negative 
expressions, we also ran analyses with parameter estimates for amygdala reactivity to 
neutral faces > shapes as a control condition, reported in the Supplemental Data. To obtain 
estimates of amygdala reactivity for each condition, we first identified functional clusters 
within the amygdala (defined structurally with the Automated Anatomical Labeling atlas) 
activated at p<.05 family-wise error (FWE) corrected within the region of interest for each 
condition in SPM8. Then, we extracted parameter estimates for the left and right amygdala 
for each condition. This procedure has been used in prior published research from the Duke 
Neurogenetics Study (Nikolova et al., 2012; Nikolova et al., 2014). Because left and right 
amygdala reactivity for our contrast of interest (fearful and angry faces>shapes) was highly 
correlated (r=.78, p<.001), we averaged across hemispheres to obtain one mean parameter 
estimate of amygdala reactivity and reduce the number of comparisons performed.
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Moderation model—Our hypothesis was that the association between amygdala reactivity 
and internalizing symptoms would be moderated by the amount of life stress experienced 
post-scanning. After parameter estimates of amygdala reactivity were extracted in SPM8, all 
subsequent analyses to test this proposed moderation model were performed in MPlus 
version 7. Thus, for Models A-C, MASQ total scores from the follow-up assessment were 
entered as the dependent variable, and extracted parameter estimates of amygdala reactivity, 
the total life stress impact score from follow-up, and the interaction between these were 
entered as predictors. The following were included as covariates: age at the most recent 
assessment, gender, childhood trauma total scores, LESS total impact scores from the 
baseline assessment, MASQ total scores at baseline, the psychopathology covariate, days 
between scanning and completing the follow-up questionnaire, and (for Model C only) the 
number of assessments contributing to the mean LESS total impact score. Predictors were 
mean-centered. Because symptoms at Time 2 were moderately skewed, MLR estimation 
was specified to estimate standard errors robust to non-normality.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Amygdala reactivity interacts with stress to predict internalizing symptoms.
• Amygdala reactivity predicted symptoms as much as 1 to 4 years after scanning.
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Fig. 1. Model A: All participants completing a post-scanning assessment (n=340)
A) Participants underwent a baseline fMRI scan to measure threat-related amygdala 
reactivity. The main effect of task (fearful and angry faces>shapes) elicited bilateral 
amygdala reactivity (thresholded at p<.05 corrected). (B) Participants were invited to 
complete an online assessment every 3 months post-scanning. The green boxes indicate the 
baseline scanning assessment and the blue boxes indicate online assessments. For Model A, 
life stress at Time 2 (as measured by the Life Events Scale for Students) and internalizing 
symptoms at Time 2 (as measured by the Mood and Anxiety Symptom Questionnaire) were 
taken from the most recent assessment completed by each participant, as indicated by the red 
boxes. (C) Depressive and anxiety symptoms at Time 2 are plotted as a function of the 
parameter estimates of threat-related amygdala reactivity and life stress post-scanning 
(groups divided into terciles). Dotted lines indicate 95% confidence bands. Internalizing 
symptoms were predicted by a significant interaction between amygdala reactivity and life 
stress experienced post-scanning, B=2.01, SE=.7, t(339)=3.08, p=.002. See also Table S1 
and Figure S1.
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Fig. 2. Model B: All participants completing an assessment at least 1-year post-scanning (n=192)
(A) For Model B, we selected data from all participants who completed a follow-up 
assessment at least 1 year post-scanning. (B) Internalizing symptoms at Time 2 as a function 
of amygdala reactivity and life stress experienced post-scanning. Internalizing symptoms 
were predicted by a significant interaction between amygdala reactivity and life stress 
experienced post-scanning, B=1.75, SE=.8, t(191)=2.33, p=.02. See also Table S3 and 
Figure S2.
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Fig. 3. Model C: Predicting symptoms reported approximately 1 year post-scanning from 
amygdala reactivity at baseline and life stress reported between the scanning session and 1 year 
post-scanning (n=99)
(A) For Model C, to obtain a prospective assessment of life stress, we selected depression 
and anxiety symptoms from the assessment completed approximately 1 year post-scanning 
(range: 365-455 days) and a mean stress score from all assessments completed before then. 
(B) Internalizing symptoms at Time 2 as a function of amygdala reactivity and life stress 
experienced post-scanning (groups created by median split). Internalizing symptoms were 
predicted by a significant interaction between amygdala reactivity and life stress 
experienced post-scanning, B=5.56, SE=1.9, t(98)=2.96, p=.003. See also Table S3 and 
Figure S3.
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Table 1
Participant Characteristics
Mean SD Min Max
Baseline (n=753)
Age (years) 19.6 1.2 18 22
Childhood trauma 33.2 7.9 25 75
Stressful life events Time 1 10.1 8.2 0 66
Internalizing symptoms Time 1 110.7 25.4 61 230
Time 2 Scores: Model A (n=340)
Age (years) 20.8 1.5 18 26
Stressful life events Time 2 4.3 5.3 0 34
Internalizing symptoms Time 2 110.7 26.4 65 214
Days between imaging and assessment 467.6 326.7 90 1402
Time 2 Scores: Model B (n=192)
Age (years) 21.4 1.4 19 26
Stressful life events Time 2 5.4 6.2 0 34
Internalizing symptoms Time 2 111.6 27.2 65 211
Days between imaging and assessment 683.0 278.6 365 1402
Time 2 Scores: Model C (n=99)
Age (years) 20.5 1.1 19 23
Stressful life events Time 2 3.3 4.2 0 27.7
Internalizing symptoms Time 2 109.9 29.2 65 230
Days between imaging and assessment 397.3 39.2 365 455
Childhood trauma=Total of all subscales of the Childhood Trauma Questionnaire; Stressful life events=Total impact score for all life events 
reported on the Life Events Scale for Students; Internalizing symptoms=Total of all subscales on the Mood and Anxiety Symptoms Questionnaire; 
SD=standard deviation.
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